Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Fixed Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.380.350.340.310.27

What is the latest Fixed Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Fixed Capital/Sales ratio of AUROBINDO PHARMA is 0.38 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.38
Mar20240.35
Mar20230.34
Mar20220.31
Mar20210.27

How is Fixed Capital/Sales of AUROBINDO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.38
8.57
Mar2024 0.35
2.94
Mar2023 0.34
9.68
Mar2022 0.31
14.81
Mar2021 0.27 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Fixed Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹69,182.0 Cr 1.4% -3.6% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.4%

-3.6%

3.5%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses